Anika Therapeutics | ANIK - Ricavi Di Vendita





I Saldi Cambiamento Data
Abbott USD 11.16B 300M 2026-03
Agenus USD 33.7M 500K 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intrexon USD 717K 511K 2024-06
J&J USD 24.1B 500M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.24B 60M 2026-03
Smith & Nephew USD 3.18B 353M 2025-12
Stryker USD 6B 1.2B 2026-03
Veracyte USD 139.07M 1.53M 2026-03
Xencor USD 4.51M 23.73M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03